Informe de inteligencia

Abridge expands clinical AI Assistant with local pathways, NACHC deal and Cochrane content

The ambient scribe company used the HLTH conference to widen the reach of its decision-support agent and the evidence it can draw on.

INSIGHTEX Editorial Desk

2 min de lectura

Abridge expands clinical AI Assistant with local pathways, NACHC deal and Cochrane contentInforme de inteligencia

What happened

San Francisco ambient scribe developer Abridge used the yearly HLTH conference in Las Vegas to unveil three updates to the Assistant, its context-aware clinical agent for decision support, MedCity News reported. The first is Local Pathways, an opt-in feature that lets the Assistant draw on a health system's own care pathways when it answers clinical questions.

A new agreement between Abridge and the National Association of Community Health Centers makes the Assistant free for 108,000 clinicians at member centers. Those centers serve roughly 52 million people, many in rural areas with limited services. Separately, publisher Wiley is licensing close to 10,000 Cochrane systematic reviews and around 4,000 Cochrane Clinical Answers, which Abridge will build into the tool.

According to the company, the Assistant reaches upward of 300 health systems that together represent over 250 million patients. Thousands of clinicians across over 75 VA medical centers also rely on it, and they put more than 40,000 questions to it last month. Clinical strategy principal Matt Troup said the local guidance feature spares clinicians from hunting through files and directories and could help reduce readmissions.

Context

Abridge's customers range from independent primary care practices to hospitals and health systems. Its push into decision support comes as others pursue similar ideas. In the same week, Viz.ai and Wolters Kluwer Health announced a partnership to bring the Viz.ai One platform into UpToDate. Troup cited a 2022 University of Chicago study estimating that primary care clinicians would need 27-hour days to meet every recommendation for every patient.

FuenteMedCity News

El boletín

La semana tecnológica, en un solo correo.

Las crónicas que merecen su tiempo, cada semana. Cancele la suscripción cuando quiera.